Charles River Laboratories, a global preclinical contract research organization, now offers BlueScreen HC Screening services for the early detection of genotoxicity. 09 September 2010
MorphoSys AG has announced a new proprietary development program against novel infectious disease targets. As part of this initiative, MorphoSys has signed a license and collaboration agreement with UK-based Absynth Biologics. 03 September 2010
Cancer Research Technology has signed an agreement with Bayer Schering Pharma AG, Germany, to evaluate new leptin antagonist peptides as potential experimental treatments, initially in the area of gynaecological diseases, including cancer. 25 August 2010
Cancer Research Technology has signed a deal to provide biotech company ValiRx PLC with the global rights to develop a promising compound to treat hormone-resistant prostate cancer. 16 August 2010
Numerate and Intellikine have announced the successful conclusion of their research collaboration to discover novel small-molecule compounds targeting the PI3K/mTOR signaling pathway. 11 August 2010
Secretary of State for Business, Innovation and Skills Vince Cable today announced the appointment of Sir John Savill as Chief Executive and Deputy Chair of the Medical Research Council. 30 July 2010
Thermo Fisher Scientific has announced a landmark collaboration that aims to introduce mass-spectrometry-based workflows and technologies into Japan to advance personalized medicine and healthcare. 27 July 2010
Royal Philips Electronics and Dako, a Danish company specializing in tissue-based cancer diagnostics, have signed an agreement to integrate a selection of Dako's image analysis applications into Philips' future digital pathology solutions. 22 July 2010
Cancer Research Technology and Medical Research Council Technology plan to ‘swap’ medical discoveries to accelerate the translation of early scientific research into patient benefit. 15 July 2010
Promega Corporation has partnered with SignalChem Pharmaceuticals to launch a complete kinase solution for the profiling of lead compounds against kinases representative of all major families of the kinome. 13 July 2010
Some of pharmaceutical’s big boys, for example Pfizer, have faced well-documented challenges over the last 12 months. The industry is only too aware of this and understands that now is the time to look at new processes and a change in the way they have traditionally done business. 07 July 2010
Marinomed Biotechnologie has signed a licensing agreement with Boehringer Ingelheim to market Marinomed’s anti-viral nasal spray for treating the common cold in Europe (except Austria and UK), Russia and CIS, South America, parts of Asia, and Australia. 29 June 2010
Teva is investing £37 million to expand its Stouffville production plant and Ontario is providing a £4.25 million grant to Teva Canada, which will retain 182 workers and hire 20 more. 02 June 2010
Evotec has announced that a compound in its alliance with Boehringer Ingelheim has advanced into clinical trials. With the initiation of phase I studies, Evotec will receive a milestone payment of €2 million. 20 May 2010
CCS Cell Culture Service, an international supplier of custom generated recombinant cell lines and custom frozen cells and membranes, has announced the opening of its Princeton, New Jersey, laboratory and office space. 14 May 2010
London, UK, 11 May 2010 London Genetics Limited, an expert in the use of pharmacogenetics in clinical drug discovery and development, is pleased to announce that the proceedings of its inaugural 2009 conference have been published in the May 2010 issue of Drug Discovery Today. The conference, ‘Harnessing Genetic Knowledge To Improve Clinical Development and Patient Care’, brought together pharma and biotech companies, academia and regulatory bodies to discuss the value that pharmacogenetics can bring to drug development. 11 May 2010
Sir James Whyte Black, the Scottish scientist who was awarded the Nobel Prize for Medicine for the invention of propranolol, has died at the age of 85 after a long illness. 23 March 2010
Professor Shankar Balasubramanian has been named as the BBSRC Innovator of the Year 2010, winning £10,000 in recognition of his work on Solexa sequencing, a high-speed genome sequencing technology. 22 March 2010
The acquisition will enhance SAGE Labs’ rodent husbandry capabilities, add new models to their product portfolio and add a strategic location for US animal distribution. 17 March 2010
Cellzome announces second major strategic drug discovery alliance with GlaxoSmithKline in inflammatory disease. 10 March 2010
Trophos, announcing the launch of MitoTarget Online on behalf of the MitoTarget consortium, hopes the site will support patients and carers and speed up finding a cure for ALS, which has attacked many people – including scientist Stephen Hawking. 09 March 2010
Construction work is underway on The Exchange, a new enterprise hub at Colworth Science Park that is being developed by Unilever and Goodman. 03 March 2010
The new facility, located in Runcorn, Cheshire, is a substantial investment for Thermo Fisher Scientific in the north of England and is a new designated Center of Excellence for its Anatomical Pathology business. 02 March 2010
Shire announced today it will actively support Rare Disease Day across the world by generating media coverage in many countries to raise awareness and understanding of rare diseases. 01 March 2010
A centre created by the Medical Research Council (MRC) and MRC Technology to fast-track the discovery and development of novel drugs opened its first call for targets recently. 08 February 2010
BioFine Europe 2010 will take place from 30–31 March and features The Peptide Conference 2010, the Synthetic Biology in Pharma conference and the BioFine Europe Exhibition. 03 February 2010
First Minister of Wales Carwyn Jones will open this year’s BioWales at the Vale of Glamorgan Hotel on March 17. 29 January 2010
Companies to collaborate on an exclusive basis on Alizé Pharma's unacylated ghrelin (AZP-01) program for the treatment of type II diabetes. 26 January 2010
BioWales will return in 2010 to showcase the bioscience sector in Wales to an international, commercial and academic audience of 400 delegates with a brokerage event and exhibition and a conference covering hot topics such as stem cells. 05 January 2010
Drug Discovery Today staff taking short break over Christmas and New Year holiday period 25 December 2009
AstraZeneca and the University of Virginia in Charlottesville recently announced that they have entered into a strategic research collaboration to enhance the development of new treatments primarily for coronary artery disease with a secondary focus on peripheral vascular disease. 24 December 2009
Merck & Co. recently announced the appointment of Dr Michael Rosenblatt as Executive Vice President and Chief Medical Officer. Dr Rosenblatt will be Merck's primary voice to the global medical community. 23 December 2009
The National Cancer Institute has entered into a research and development collaboration with Mayo Clinic to expand on recent research discoveries at Mayo, where researchers have demonstrated the importance of a key protein involved in pancreatic and lung cancer. 09 December 2009
Domainex Ltd. has released the next generation of its LeadBuilder virtual screening technology. LeadBuilder is the proprietary lead generation platform developed by Domainex to provide unusually rapid and cost-effective access to high-quality small-molecule drug leads, particularly against novel or difficult target proteins. 03 December 2009
Research efforts to help the world's ageing population live longer, healthier lives have been given a major boost with the announcement of six new transatlantic research projects that aim to understanding the biology of the ageing process. 02 December 2009
Private industry has been urged to join a public sector commitment to fund advanced manufacturing research and development in bioprocessing. 26 November 2009
MedImmune has announced the winners of its European research abstract competition, which highlights the work of tomorrow's budding scientific leaders in cancer research. 25 November 2009
'Visions of Discovery', a new exhibition featuring stunning images arising from biological and medical research, has opened at the University of Dundee. 16 November 2009
Astex Therapeutics Limited announced recently that it has entered into a new collaboration agreement with GlaxoSmithKline (GSK) to discover, develop and commercialize novel compounds directed against multiple therapeutic targets of interest to GSK. 13 November 2009
The GSM Association today announced that it has signed a Memorandum of Understanding with the University of Manchester to establish an m-Health Innovation Centre in Manchester, which will act as a UK focus for m-Health activity. 11 November 2009
Astex Therapeutics Limited recently announced the signing of a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute to collaborate on the study of its novel small-molecule HSP90 inhibitor, AT13387, for the treatment of cancer. 06 November 2009
A new spin out company from the Medical Research Council’s Laboratory of Molecular Biology in Cambridge UK was announced this week. Bicycle Therapeutics is a new biotechnology company developing a novel technology platform for the creation of a new class of therapeutic entity which combines the most desirable features of small molecules and biologics. 23 October 2009
ELRIG (The European Laboratory Robotic Interest Group) has a mission to give back to the Industry whenever they can and to encourage the growth of Innovative Technology. It was therefore very appropriate that they agreed to Sponsor the Technobotts in their venture to enter the RoboCup 2010 in Singapore. 22 October 2009
Dr Leroy Hood-led venture has secured $30 million Series A financing from InterWest Partners, Wellcome Trust and dievini. 15 October 2009
Olesoxime in ongoing pivotal efficacy study for amyotrophic lateral sclerosis. 08 October 2009
BioFocus has recently launched its new microsite, www.SilenceSelect.com, which is dedicated to the SilenceSelect® and FLeXSelect® adenoviral technology. 08 October 2009
Major new collaboration announced at Clinton Global Initiative Annual Meeting. 06 October 2009
Sanofi-aventis announced recently that it has signed a binding agreement for the acquisition of Fovea Pharmaceuticals SA (‘Fovea‘), a privately held French research and development biopharmaceutical company, focused on ocular diseases. 05 October 2009
Multi-disciplinary healthcare giant Abbott Laboratories has fought off competition from Nycomed to secure the $6.6 billion acquisition of Solvay's pharmaceutical business. 02 October 2009
The first ever BBSRC Diamond Professorial Fellow, Professor So Iwata, has been awarded the 2009 Aminoff Prize by the Royal Swedish Academy of Sciences for his work in the field of crystallography. 30 September 2009
Karus Therapeutics Ltd, a company developing small-molecule drugs to treat cancer and inflammation, announced recently that it has signed an agreement to collaborate with Professor Bart Vanhaesebroeck at Queen Mary, University of London. 29 September 2009
Vaccine developers with insight into the latest advances will be drivers of innovation within the vaccine industry, yet there is a lack of available training courses in the field. 25 September 2009
ID Business Services (IDBS) announced yesterday that IDBS customer Dr Martin Vanderlaan, Director, Analytical Operations at Genentech, will present ‘Implementing an Electronic Lab Notebook for a Large Bioprocess Organisation’ at IQPC’s ELN and Advanced Lab Solutions Conference in Brussels, Belgium. 25 September 2009
AstraZeneca and Nektar Therapeutics announced recently that they have entered into a worldwide license agreement for two drug development programmes: NKTR-118, a late-stage investigational product being evaluated for the treatment of opioid-induced constipation, and the NKTR-119 programme, an early-stage programme that is intended to deliver products for the treatment of pain without constipation side-effects. 24 September 2009
Cancer Research UK is set to extend its drug discovery effort by investing up to £16 million in two new Drug Discovery Programmes at the Paterson Institute for Cancer Research in Manchester and the Beatson Institute for Cancer Research in Glasgow. 22 September 2009
The Drug Information Association (DIA) has announced the hiring of Paul Pomerantz, MBA, CAE, as its new worldwide executive director. 17 September 2009
Innovative Medicines Initiative, the public–private partnership between the European Commission and the European pharmaceutical industry (represented by EFPIA), today made its first major announcement of the success of the collaboration. 15 September 2009
Medical diagnosis requires doctors to make difficult decisions, beginning with the selection of the right diagnostic method. 24 August 2009
Deal combines ChemNavigator's database of searchable chemical compounds and cheminformatics tools with Sigma-Aldrich chemical services. 18 August 2009
The international Biological and Environmental Reference Materials 12 symposium, which was organized by LGC in conjunction with the BERM committee, was opened by Lord Drayson, UK Minister for Science and Innovation. 12 August 2009
Debiopharm Group and MSM Protein Technologies have announced the signature of an exclusive agreement for the development and commercialization of Debio 0929, an antibody targeting a G-protein-coupled receptor (GPCR) to be developed into a new oncology therapeutic drug. 30 July 2009
Axel Ullrich, PhD, director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel cancer therapies including Herceptin® (trastuzumab), has been announced as the winner of the 2009 Dr Paul Janssen Award for Biomedical Research. 30 July 2009
MorphoSys and the University of Melbourne have recently announced an agreement to cooperate on investigating new therapeutic applications for MorphoSys’s MOR103 program. 29 July 2009
Amgen and GlaxoSmithKline recently announced a collaboration in which the companies will share commercialization of Amgen’s monoclonal antibody denosumab for postmenopausal osteoporosis in Europe, Australia, New Zealand and Mexico once the product is approved in these countries. 28 July 2009
Roche and Google.org have recently started a joint project to demonstrate the feasibility of developing a multidisciplinary surveillance, research and response system. This system will enhance the ability to predict and prevent emerging infectious diseases in East Africa. 28 July 2009
Cancer Research Technology, Merck Serono, Cancer Research UK, Cardiff University and The Institute of Cancer Research are set to begin a new research collaboration that will provide substantial investment in research on the WNT signalling pathway in the hope of finding new drug targets. 27 July 2009
The pharmaceutical sector is set to get its own body dedicated to identifying and addressing key skills issues. 23 July 2009
Ontario is joining forces with Pfizer Inc. and leading Ontario research institutions to develop a new generation of drugs to fight colorectal cancer. 23 July 2009
Email Address
Password
Forgotten login?